Assignee
FELDAN BIO INC
CA·7 granted patents·4 pending applications·65 citations·filing 2016–2023
Top patents by PatentIndex Score
11 records- 0195US9738687B2Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to sameFELDAN BIO INC·Filed 2016·Granted Aug 22, 2017·33 cites·20 claims
- 0293US9982267B2Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to sameFELDAN BIO INC·Filed 2017·Granted May 29, 2018·18 cites·20 claims
- 0392US12060387B2Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to sameFELDAN BIO INC·Filed 2020·Granted Aug 13, 2024·3 cites·19 claims
- 0490US10633421B2Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to sameFELDAN BIO INC·Filed 2017·Granted Apr 28, 2020·6 cites·37 claims
- 0587US11629170B2Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to sameFELDAN BIO INC·Filed 2017·Granted Apr 18, 2023·5 cites·17 claims
- 0661US12286632B2Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to sameFELDAN BIO INC·Filed 2022·Granted Apr 29, 2025·0 cites·20 claims
- 0754US2026033466A1Method and animal model for inducing bcc tumorsFELDAN BIO INC·Filed 2023·Application pending·0 cites
- 0850US2024197896A1Synthetic peptide shuttle agent bioconjugates for intracellular cargo deliveryFELDAN BIO INC·Filed 2022·Application pending·0 cites
- 0948US2023399661A1Shuttle agent peptides of minimal length and variants thereof adapted for transduction of cas9-rnp and other nucleoprotein cargosFELDAN BIO INC·Filed 2021·Application pending·0 cites
- 1046US2023383291A1Peptide-based transduction of non-anionic polynucleotide analogs for gene expression modulationFELDAN BIO INC·Filed 2021·Application pending·0 cites
- 1140US12428447B2Peptide-based non-proteinaceous cargo deliveryFELDAN BIO INC·Filed 2020·Granted Sep 30, 2025·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when FELDAN BIO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →